Cancer Immunotherapy Month I CRI-Irvington Postdoctoral Fellow Dr. Michael Papanicolaou

How are CRI-funded researchers discovering a world #Immune2Cancer? CRI-Irvington Postdoctoral Fellow Dr. Michael Papanicolaou of the Albert Einstein College of Medicine shares insights into his work during Cancer Immunotherapy Month.
-
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. www.cancerrese...
Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.